Mechanistically, the key role of innate immunity has been further supported by the recent report that genetic ablation of the key adaptor of innate immunity, MyD88, affords protection from T1D in specific pathogen-free NOD mice [15]. This evidence concerns the gene MYD88 and type 1 diabetes mellitus.